Oxford Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Oxford Asset Management's EW Position: Q1 2020 in Review
Oxford Asset Management sold out of Edwards Lifesciences (EW) in Q1 2020, closing a stake of 109,575 shares — an estimated $8.52M sold.
Oxford Asset Management first reported a position in EW in Q1 2014 and held it in 13 quarters. The position peaked at $15.2M in Q1 2015. 1,019 funds tracked by Wall St. Rank hold EW as of Q1 2020.
- Oxford Asset Management reported no remaining Edwards Lifesciences position as of Q1 2020 after selling out during the quarter.
- Oxford Asset Management sold 109,575 Edwards Lifesciences shares in Q1 2020, an estimated $8.52M.
- Oxford Asset Management first reported a position in Edwards Lifesciences in Q1 2014 and held it in 13 quarters.
- Oxford Asset Management's Edwards Lifesciences position peaked at $15.2M in Q1 2015.
- 1,019 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2020.
Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.